Atezolizumab in First Line NSCLC: Early Clinical Results from the IMpower150 Trial (BMIC-020)

Dr. Jack West reviews the preliminary clinical results on the IMpower150 trial that tested the value of adding the immune checkpoint inhibitor atezolizumab to carbo/paclitaxel/bevacizumab in patients ... Author: BeaconMedIC Added: 12/18/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts